about
Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humansNovel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.Pharmacokinetic/pharmaco-dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ(9)-tetrahydrocannabinol challenge tests.Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short- and long-term pharmacokinetics.Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.Subjective Effects of Ethanol, Morphine, Δ(9)-Tetrahydrocannabinol, and Ketamine Following a Pharmacological Challenge Are Related to Functional Brain Connectivity.Manipulating brain connectivity with δ⁹-tetrahydrocannabinol: a pharmacological resting state FMRI study.A Brief Background on Cannabis: From Plant to Medical Indications
P50
Q34320289-2D596C6F-7498-4EE2-864C-783C8DC41CDFQ36087946-59984FDA-B832-4778-9994-0EBFBFC76E09Q38937489-E129A6F2-6275-4B95-B29B-599804B460C4Q39113008-CB1AD14E-BBD5-4858-9B75-B9A7092B89D2Q41893598-9ECA53CB-D57E-4BF0-8263-C4ABB797B130Q47650384-B454AC08-7DA8-46D2-94B6-96FDDC203E99Q48412203-523C6806-D67B-4582-B57A-2137AA4E7C92Q91111377-91FC9E55-F715-4DFB-AC46-DC19527D9B64
P50
description
researcher ORCID ID = 0000-0003-3453-9744
@en
name
Linda E Klumpers
@ast
Linda E Klumpers
@en
Linda E Klumpers
@nl
type
label
Linda E Klumpers
@ast
Linda E Klumpers
@en
Linda E Klumpers
@nl
prefLabel
Linda E Klumpers
@ast
Linda E Klumpers
@en
Linda E Klumpers
@nl
P21
P31
P496
0000-0003-3453-9744